How many patents does
Cyclacel have?
patents
265
families
52
granted
81
applications
184
US
54
EP
36
CN
24
GB
21
JP
15
WO
11
KR
5
RoW
99
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Cyclacel
Top ten assignees appearing on patents
2009 - 2018
| cyclacel | 230 |
| cancer research technology | 20 |
| cancer rec tech | 3 |
| sajklasel | 2 |
| kehnsehr reserch teknolodzhi | 1 |
2009
| cyclacel | 54 |
| cancer research technology | 7 |
| cancer rec tech | 2 |
2018
| cyclacel | 12 |
Cyclacel
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| pyrimidine derivatives as protein kinase inhibitors | 26 | 2007 |
| crystalline forms of a purine derivative | 24 | 2010 |
| combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as deci… 🛈 | 22 | 2008 |
| crystalline pyrimidine nucleoside derivatives suspensions in capsules | 20 | 2005 |
| preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmitoyl-1… 🛈 | 19 | 2008 |
| 2,6,9-substituted purine derivatives having antiproliferative properties | 14 | 2007 |
| use of sapacitabine to treat proliferative disease | 11 | 2007 |
| pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2a]pyrazin-1-one compounds | 9 | 2005 |
| combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-c… 🛈 | 7 | 2006 |
| dosage regimen for sapacitabine and seliciclib | 7 | 2012 |